Vivos Therapeutics Inc
VVOS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.58M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.58 Million |
|---|---|
| Enterprise Value | $11.95 Million |
| Earnings per Share | $-2.06 |
| Beta | 6.07 |
| Outstanding Shares | 17,681,945 |
Return
| Return on Equity | 668.86% |
|---|---|
| Return on Assets | -105.69% |
| Return on Invested Capital | -615.31% |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | -0.59 |
| Price to Sales | 0.11 |
| Price to Book Ratio | -0.11 |
| Enterprise Value to Revenue | 0.57 |
| Enterprise Value to EBIT | -0.52 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.02 |
| Debt to Equity | -3.18 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.31
Consensus analyst estimateRevenue Estimate
$5.55 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$-0.30
Consensus analyst estimateRevenue Estimate
$5.47 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.06%▼ 2.94% |
|---|---|
| Total Invested | $1,578▼ 99.35% |
| Investors Holding | 4▼ 18.00% |
About Vivos Therapeutics Inc
115 employees
Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including obstructive sleep apnea (OSA). Vivos believes that...